Nexalin Research Development vs Selling And Marketing Expenses Analysis

NXL Stock

USD 0.70 0.02 2.78%

Nexalin Technology financial indicator trend analysis is infinitely more than just investigating Nexalin Technology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nexalin Technology is a good investment. Please check the relationship between Nexalin Technology Research Development and its Selling And Marketing Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.

Research Development vs Selling And Marketing Expenses

Research Development vs Selling And Marketing Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nexalin Technology Research Development account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Nexalin Technology's Research Development and Selling And Marketing Expenses is 0.83. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Nexalin Technology, assuming nothing else is changed. The correlation between historical values of Nexalin Technology's Research Development and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Nexalin Technology are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Research Development i.e., Nexalin Technology's Research Development and Selling And Marketing Expenses go up and down completely randomly.

Correlation Coefficient

0.83

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Research Development

Selling And Marketing Expenses

Most indicators from Nexalin Technology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nexalin Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.Sales General And Administrative To Revenue is expected to rise to 54.81 this year, although the value of Selling General Administrative will most likely fall to about 4 M.

	2021	2022	2023	2024 (projected)
Interest Expense	82.3K	59.4K	38.8K	54.4K
Depreciation And Amortization	537.0	172.2K	4.3K	4.0K

Interest Expense Depreciation And Amortization

Nexalin Technology fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt
Total Assets		-0.47	0.56	0.16	0.95	0.84	0.72	-0.48	-0.71	0.23	0.38	0.43	0.37	1.0	0.07	0.29	-0.8	0.93	0.84	0.86	-0.01	1.0	-0.22	0.9	0.83	-0.79
Short Long Term Debt Total	-0.47		-0.32	0.55	-0.67	-0.85	0.24	0.94	0.86	0.46	-0.59	-0.99	-0.99	-0.43	-0.32	-0.81	0.74	-0.69	-0.86	-0.79	0.71	-0.45	0.95	-0.71	-0.87	0.62
Other Current Liab	0.56	-0.32		0.59	0.46	0.43	0.35	-0.49	-0.7	0.64	0.62	0.26	0.23	0.56	0.63	0.32	-0.82	0.47	0.49	0.68	0.41	0.56	-0.02	0.65	0.46	-0.73
Total Current Liabilities	0.16	0.55	0.59		-0.12	-0.3	0.52	0.31	0.08	0.99	0.17	-0.59	-0.61	0.19	0.36	-0.48	-0.13	-0.07	-0.26	-0.01	0.98	0.17	0.78	0.06	-0.31	-0.23
Total Stockholder Equity	0.95	-0.67	0.46	-0.12		0.96	0.54	-0.63	-0.8	-0.04	0.38	0.65	0.6	0.94	0.05	0.53	-0.82	0.95	0.95	0.9	-0.3	0.95	-0.49	0.91	0.95	-0.76
Net Tangible Assets	0.84	-0.85	0.43	-0.3	0.96		0.28	-0.8	-0.89	-0.21	0.5	0.84	0.8	0.82	0.16	0.69	-0.85	0.92	1.0	0.93	-0.49	0.83	-0.7	0.9	1.0	-0.77
Property Plant And Equipment Net	0.72	0.24	0.35	0.52	0.54	0.28		0.25	-0.09	0.5	-0.17	-0.29	-0.35	0.76	-0.31	-0.25	-0.28	0.47	0.25	0.29	0.47	0.74	0.45	0.39	0.25	-0.28
Net Debt	-0.48	0.94	-0.49	0.31	-0.63	-0.8	0.25		0.93	0.19	-0.81	-0.95	-0.94	-0.44	-0.61	-0.76	0.84	-0.68	-0.84	-0.85	0.49	-0.46	0.83	-0.77	-0.82	0.79
Retained Earnings	-0.71	0.86	-0.7	0.08	-0.8	-0.89	-0.09	0.93		-0.03	-0.77	-0.85	-0.82	-0.69	-0.56	-0.75	0.96	-0.8	-0.93	-0.96	0.29	-0.7	0.66	-0.9	-0.91	0.9
Accounts Payable	0.23	0.46	0.64	0.99	-0.04	-0.21	0.5	0.19	-0.03		0.3	-0.49	-0.51	0.26	0.46	-0.4	-0.23	0.01	-0.16	0.1	0.94	0.24	0.7	0.16	-0.22	-0.35
Cash	0.38	-0.59	0.62	0.17	0.38	0.5	-0.17	-0.81	-0.77	0.3		0.6	0.59	0.35	0.9	0.36	-0.76	0.54	0.57	0.73	0.01	0.37	-0.4	0.7	0.51	-0.87
Non Current Assets Total	0.43	-0.99	0.26	-0.59	0.65	0.84	-0.29	-0.95	-0.85	-0.49	0.6		1.0	0.39	0.34	0.83	-0.7	0.65	0.85	0.77	-0.74	0.41	-0.96	0.68	0.85	-0.61
Non Currrent Assets Other	0.37	-0.99	0.23	-0.61	0.6	0.8	-0.35	-0.94	-0.82	-0.51	0.59	1.0		0.33	0.35	0.83	-0.67	0.61	0.82	0.73	-0.75	0.36	-0.97	0.64	0.82	-0.58
Cash And Short Term Investments	1.0	-0.43	0.56	0.19	0.94	0.82	0.76	-0.44	-0.69	0.26	0.35	0.39	0.33		0.06	0.28	-0.79	0.91	0.81	0.83	0.03	1.0	-0.18	0.88	0.8	-0.77
Net Receivables	0.07	-0.32	0.63	0.36	0.05	0.16	-0.31	-0.61	-0.56	0.46	0.9	0.34	0.35	0.06		0.28	-0.55	0.16	0.25	0.45	0.24	0.07	-0.16	0.39	0.18	-0.66
Common Stock Shares Outstanding	0.29	-0.81	0.32	-0.48	0.53	0.69	-0.25	-0.76	-0.75	-0.4	0.36	0.83	0.83	0.28	0.28		-0.57	0.37	0.7	0.58	-0.61	0.29	-0.78	0.44	0.71	-0.42
Non Current Liabilities Total	-0.8	0.74	-0.82	-0.13	-0.82	-0.85	-0.28	0.84	0.96	-0.23	-0.76	-0.7	-0.67	-0.79	-0.55	-0.57		-0.85	-0.89	-0.98	0.08	-0.8	0.49	-0.95	-0.86	0.94
Inventory	0.93	-0.69	0.47	-0.07	0.95	0.92	0.47	-0.68	-0.8	0.01	0.54	0.65	0.61	0.91	0.16	0.37	-0.85		0.92	0.93	-0.25	0.93	-0.49	0.97	0.91	-0.84
Other Current Assets	0.84	-0.86	0.49	-0.26	0.95	1.0	0.25	-0.84	-0.93	-0.16	0.57	0.85	0.82	0.81	0.25	0.7	-0.89	0.92		0.95	-0.45	0.83	-0.7	0.92	1.0	-0.82
Other Stockholder Equity	0.86	-0.79	0.68	-0.01	0.9	0.93	0.29	-0.85	-0.96	0.1	0.73	0.77	0.73	0.83	0.45	0.58	-0.98	0.93	0.95		-0.22	0.85	-0.57	0.99	0.93	-0.94
Total Liab	-0.01	0.71	0.41	0.98	-0.3	-0.49	0.47	0.49	0.29	0.94	0.01	-0.74	-0.75	0.03	0.24	-0.61	0.08	-0.25	-0.45	-0.22		0.0	0.89	-0.14	-0.49	-0.03
Total Current Assets	1.0	-0.45	0.56	0.17	0.95	0.83	0.74	-0.46	-0.7	0.24	0.37	0.41	0.36	1.0	0.07	0.29	-0.8	0.93	0.83	0.85	0.0		-0.21	0.9	0.82	-0.78
Short Term Debt	-0.22	0.95	-0.02	0.78	-0.49	-0.7	0.45	0.83	0.66	0.7	-0.4	-0.96	-0.97	-0.18	-0.16	-0.78	0.49	-0.49	-0.7	-0.57	0.89	-0.21		-0.48	-0.73	0.37
Common Stock	0.9	-0.71	0.65	0.06	0.91	0.9	0.39	-0.77	-0.9	0.16	0.7	0.68	0.64	0.88	0.39	0.44	-0.95	0.97	0.92	0.99	-0.14	0.9	-0.48		0.9	-0.94
Property Plant Equipment	0.83	-0.87	0.46	-0.31	0.95	1.0	0.25	-0.82	-0.91	-0.22	0.51	0.85	0.82	0.8	0.18	0.71	-0.86	0.91	1.0	0.93	-0.49	0.82	-0.73	0.9		-0.77
Long Term Debt	-0.79	0.62	-0.73	-0.23	-0.76	-0.77	-0.28	0.79	0.9	-0.35	-0.87	-0.61	-0.58	-0.77	-0.66	-0.42	0.94	-0.84	-0.82	-0.94	-0.03	-0.78	0.37	-0.94	-0.77

Click cells to compare fundamentals

Nexalin Technology Account Relationship Matchups

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nexalin Technology using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:

How To Invest In Nexalin

Details

Is Nexalin Stock a good investment?

Details

What is Nexalin Technology's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Nexalin Stock analysis

When running Nexalin Technology's price analysis, check to measure Nexalin Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexalin Technology is operating at the current time. Most of Nexalin Technology's value examination focuses on studying past and present price action to predict the probability of Nexalin Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexalin Technology's price. Additionally, you may evaluate how the addition of Nexalin Technology to your portfolios can decrease your overall portfolio volatility.

	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios

Is Nexalin Technology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.67)

Revenue Per Share

0.015

Quarterly Revenue Growth

(0.47)

Return On Assets

(0.64)

Return On Equity

(1.07)

The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nexalin Research Development vs Selling And Marketing Expenses Analysis

Research Development vs Selling And Marketing Expenses

Research Development vs Selling And Marketing Expenses Correlation Analysis

Correlation Coefficient

Research Development

Selling And Marketing Expenses

Nexalin Technology fundamental ratios Correlations

Nexalin Technology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Nexalin Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Other Current Assets	+ 1.0	Net Tangible Assets
Property Plant Equipment	+ 1.0	Net Tangible Assets
Non Currrent Assets Other	+ 1.0	Non Current Assets Total
Total Current Assets	+ 1.0	Cash And Short Term Investments

Non Currrent Assets Other	- 0.99	Short Long Term Debt Total
Non Current Assets Total	- 0.99	Short Long Term Debt Total
Other Stockholder Equity	- 0.98	Non Current Liabilities Total
Short Term Debt	- 0.97	Non Currrent Assets Other
Short Term Debt	- 0.96	Non Current Assets Total
Other Stockholder Equity	- 0.96	Retained Earnings